🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

503 results for “Regeneron” Clear

  1. REGN7508

    Regeneron UK Limited

    Venous Thromboembolism (VTE)

    phase 3 small molecule active

    2 trials

  2. Ranibizumab

    Regeneron UK Limited

    Macular Degeneration

    phase 3 small molecule completed

    2 trials

  3. Ravulizumab

    Regeneron UK Limited

    Paroxysmal Nocturnal Hemoglobinuria

    phase 3 small molecule active

    1 trial

  4. Rilonacept

    Regeneron UK Limited

    Acute Gout Flare

    phase 3 small molecule completed

    1 trial

  5. Rilonacept

    Regeneron UK Limited

    Gout

    phase 3 mab completed

    3 trials

  6. Rilonacept 80 mg

    Regeneron UK Limited

    Intercritical Gout

    phase 3 small molecule completed

    1 trial

  7. SAR153191 (REGN88)

    Regeneron UK Limited

    Rheumatoid Arthritis

    phase 3 small molecule completed

    2 trials

  8. Sarilumab

    Regeneron UK Limited

    RA

    phase 3 small molecule completed

    1 trial

  9. Sarilumab

    Regeneron UK Limited

    COVID-19

    phase 3 small molecule completed

    1 trial

  10. Sarilumab SAR153191

    Regeneron UK Limited

    Corona Virus Infection

    phase 3 small molecule completed

    1 trial

  11. Sarilumab SAR153191

    Regeneron UK Limited

    Giant Cell Arteritis

    phase 3 small molecule terminated

    1 trial

  12. Sarilumab SAR153191 (REGN88)

    Regeneron UK Limited

    Polymyalgia Rheumatica

    phase 3 small molecule terminated

    1 trial

  13. Suptavumab 30 mg/kg

    Regeneron UK Limited

    Respiratory Syncytial Virus Infections

    phase 3 small molecule completed

    1 trial

  14. VEGF Trap-Eye (BAY86-5321)

    Regeneron UK Limited

    Myopia, Pathological

    phase 3 mab completed

    1 trial

  15. VEGF Trap-Eye (BAY86-5321)

    Regeneron UK Limited

    Diabetes Mellitus

    phase 3 mab completed

    1 trial

  16. VEGF Trap-Eye (BAY86-5321)

    Regeneron UK Limited

    Macular Edema

    phase 3 mab completed

    1 trial

  17. VEGF Trap-Eye 2.0mg

    Regeneron UK Limited

    Macular Edema Secondary to Central Retinal Vein Occlusion

    phase 3 mab completed

    1 trial

  18. aflibercept

    Regeneron UK Limited

    Retinopathy of Prematurity

    phase 3 small molecule completed

    1 trial

  19. aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)

    Regeneron UK Limited

    Ovarian Neoplasms

    phase 3 small molecule completed

    2 trials

  20. aflibercept 8 mg PFS

    Regeneron UK Limited

    Diabetic Macular Edema (DME)

    phase 3 small molecule completed

    1 trial

  21. alirocumab SAR236553 (REGN727)

    Regeneron UK Limited

    Hypercholesterolemia

    phase 3 small molecule completed

    8 trials

  22. alirocumab SAR236553 (REGN727)

    Regeneron UK Limited

    Hypercholesterolaemia

    phase 3 small molecule completed

    2 trials

  23. casirivimab+imdevimab

    Regeneron UK Limited

    Immunocompromised

    phase 3 small molecule terminated

    1 trial

  24. casirivimab+imdevimab combination therapy

    Regeneron UK Limited

    COVID-19

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources